Multi-factor normalisation of viral counts from wastewater improves the detection accuracy of viral disease in the community
Research output: Contribution to journal › Article › peer-review
Standard Standard
In: Environmental Technology & Innovation, Vol. 36, 103720, 05.11.2024.
Research output: Contribution to journal › Article › peer-review
HarvardHarvard
APA
CBE
MLA
VancouverVancouver
Author
RIS
TY - JOUR
T1 - Multi-factor normalisation of viral counts from wastewater improves the detection accuracy of viral disease in the community
AU - Pellett, Cameron
AU - Farkas, Kata
AU - Williams, Rachel
AU - Wade, Matthew J
AU - Weightman, Andrew J
AU - Jameson, Ellie
AU - Cross, Gareth
AU - Jones, Davey L.
PY - 2024/11/5
Y1 - 2024/11/5
N2 - The detection of viruses (e.g. SARS-CoV-2, norovirus) in wastewater represents an effective way to monitor the prevalence of these pathogens circulating within the community. However, accurate quantification of viral concentrations in wastewater, proportional to human input, is constrained by a range of uncertainties, including (i) dilution within the sewer network, (ii) degradation of viral RNA during wastewater transit, (iii) catchment population and facility use, (iv) efficiency of viral concentration and extraction from wastewater, and (v) inhibition of amplification during the RT-qPCR step. Here, we address these uncertainties by investigating several potential normalisation factors including the concentration of ammonium and orthophosphate. A faecal indicator virus (crAssphage), and the recovery of the process-control viruses (murine norovirus and bacteriophage Phi6), used for quality control during the RT-qPCR step, were also considered. We found that multi-factor normalisation of SARS-CoV-2 RT-qPCR data was optimal using a combination of crAssphage, process-control virus recovery, and concentration efficiency to improve prediction accuracy relative to clinical test data. Using multi-normalised SARS-CoV-2 RT-qPCR data, we found a lasso regression model with random forest modelled residuals lowers the prediction error of positives by 46 %, compared to a single linear regression using raw data. This multi-normalised approach enables more accurate wastewater-based predictions of clinical cases up to five days in advance of clinical data, identifying trends in disease prevalence before clinical testing, and demonstrates the potential to improve viral pathogen detection for a range of currently monitored and emerging diseases.
AB - The detection of viruses (e.g. SARS-CoV-2, norovirus) in wastewater represents an effective way to monitor the prevalence of these pathogens circulating within the community. However, accurate quantification of viral concentrations in wastewater, proportional to human input, is constrained by a range of uncertainties, including (i) dilution within the sewer network, (ii) degradation of viral RNA during wastewater transit, (iii) catchment population and facility use, (iv) efficiency of viral concentration and extraction from wastewater, and (v) inhibition of amplification during the RT-qPCR step. Here, we address these uncertainties by investigating several potential normalisation factors including the concentration of ammonium and orthophosphate. A faecal indicator virus (crAssphage), and the recovery of the process-control viruses (murine norovirus and bacteriophage Phi6), used for quality control during the RT-qPCR step, were also considered. We found that multi-factor normalisation of SARS-CoV-2 RT-qPCR data was optimal using a combination of crAssphage, process-control virus recovery, and concentration efficiency to improve prediction accuracy relative to clinical test data. Using multi-normalised SARS-CoV-2 RT-qPCR data, we found a lasso regression model with random forest modelled residuals lowers the prediction error of positives by 46 %, compared to a single linear regression using raw data. This multi-normalised approach enables more accurate wastewater-based predictions of clinical cases up to five days in advance of clinical data, identifying trends in disease prevalence before clinical testing, and demonstrates the potential to improve viral pathogen detection for a range of currently monitored and emerging diseases.
U2 - 10.1016/j.eti.2024.103720
DO - 10.1016/j.eti.2024.103720
M3 - Article
VL - 36
JO - Environmental Technology & Innovation
JF - Environmental Technology & Innovation
SN - 2352-1864
M1 - 103720
ER -